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It has been postulated that a number of the central effects of ethanol are mediated via
ethanol metabolites: acetaldehyde and acetate. Ethanol is known to produce a large
variety of behavioral actions such anxiolysis, narcosis, and modulation of locomotion.
Acetaldehyde contributes to some of those effects although the contribution of acetate
is less known. In the present studies, rats and mice were used to assess the acute and
chronic effects of acetate after central or peripheral administration. Male Sprague-Dawley
rats were used for the comparison between central (intraventricular, ICV) and peripheral
(intraperitoneal, IP) administration of acute doses of acetate on locomotion. CD1 male
mice were used to study acute IP effects of acetate on locomotion, and also the effects
of chronic oral consumption of acetate (0, 500, or 1000mg/l, during 7, 15, 30, or 60
days) on ethanol- (1.0, 2.0, 4.0, or 4.5 g/kg, IP) induced locomotion, anxiolysis, and loss
of righting reflex (LORR). In rats, ICV acetate (0.7–2.8μmoles) reduced spontaneous
locomotion at doses that, in the case of ethanol and acetaldehyde, had previously
been shown to stimulate locomotion. Peripheral acute administration of acetate also
suppressed locomotion in rats (25–100mg/kg), but not in mice. In addition, although
chronic administration of acetate during 15 days did not have an effect on spontaneous
locomotion in an open field, it blocked ethanol-induced locomotion. However, ethanol-
induced anxiolysis was not affected by chronic administration of acetate. Chronic
consumption of acetate (up to 60 days) did not have an effect on latency to, or duration
of LORR induced by ethanol, but significantly increased the number of mice that did not
achieve LORR. The present work provides new evidence supporting the hypothesis that
acetate should be considered a centrally-active metabolite of ethanol that contributes to
some behavioral effects of this alcohol, such as motor suppression.
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INTRODUCTION
Acetate is a short-chain fatty acid formed as the final step in
ethanol oxidation. The oxidative metabolism of ethanol into
acetaldehyde takes place in several organs, and can involve
multiple enzymes, including alcohol dehydrogenase (ADH),
cytochrome P450 2E1 (CYP2E1), and catalase. Acetaldehyde is
then metabolized mainly by aldehyde dehydrogenase (ALDH)
into acetate. Following ethanol ingestion, approximately 70% of
the acetate generated through oxidative metabolism is released
from the liver into systemic circulation (Busch, 1953; Van den
Berg et al., 1966). Acetate can be detected in plasma after ethanol
administration, because the portion that has not been metab-
olized hepatically is released into the blood. Acetate is then
redistributed throughout the body, metabolized in extra-hepatic
organs (Lundquist et al., 1962), rapidly taken up into the brain by
a carrier-mediated process (Oldendorf, 1973), and also is actively
metabolized in the brain (Cullen and Carlen, 1992). An alterna-
tive central source of acetate is brain ethanol metabolism. It has
been demonstrated (Zimatkin et al., 2006) that pharmacologi-
cal manipulations that reduce catalase activity also reduce the
amount of acetate detected in rat and mice brain homogenates.
Moreover, when brain homogenates from CYP2E1 KO mice
where incubated with ethanol plus a catalase inhibitor, there was
a significant reduction of acetate formation, an effect which was
not observed in brain homogenates from catalase-deficient mice
(Zimatkin et al., 2006). Pharmacological inhibition of CYP2E1
also leads to significant decreases in acetate accumulation in
rat brain homogenates. Moreover, enzymatic inhibition of ADH
and ALDH also reduced acetate levels (Zimatkin et al., 2006).
These results demonstrate that acetate can be formed in the
brain via ethanol metabolism and that the enzymatic systems
involved in this process are some of the ones required to form
acetaldehyde.
Acetate has been demonstrated to have specific effects on
behavior. Peripherally administered acetate increased the time
off a treadmill, a measure of motor incoordination in rats, and
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suppressed locomotion in mice (Carmichael et al., 1991; Israel
et al., 1994). In fact, peripherally injected acetate has been demon-
strated to be three times more potent than ethanol at suppress-
ing locomotion in mice (Israel et al., 1994). Moreover, acetate
injected peripherally or in the brain ventricles also suppressed
food-reinforced lever pressing on a FR5 schedule of reinforce-
ment, which generates high levels of performance (Arizzi et al.,
2003; McLaughlin et al., 2008). Thus, it has been suggested that
acetate is involved mainly in the depressant effects of ethanol
(Carmichael et al., 1991; Israel et al., 1994; Arizzi et al., 2003;
Correa et al., 2003). Consistent with this idea, acetate can mimic
some of the motor suppressant, ataxic, or sedative effects of
ethanol. For instance, general anesthesia is potentiated in a dose-
dependent fashion by ethanol as well as acetate (Carmichael et al.,
1991; Campisi et al., 1997). Acetate seems to mediate tolerance
to the loss of the righting reflex (LORR) produced by ethanol.
Repeated administration of ethanol [3.5 g/kg, intraperitoneal (IP)
during 7 days] to outbred rats, resulted in tolerance to LORR
induced by ethanol and to higher concentrations of acetate in
different areas of the brain compared to acutely treated animals
(Kiselevski et al., 2003). Moreover, higher amounts of acetate are
formed in short sleeping (SS) rats, which have an inborn toler-
ance to the LORR induced by high doses of ethanol, relative to
the long sleeping (LS) substrain (Zimatkin et al., 2011).
Because direct administration of ethanol and acetaldehyde
seem to have different motor effects depending on the route of
administration (for a review see Correa et al., 2012), the present
experiments addressed the potential differences between periph-
eral and central injections of acetate on locomotor activity in
rats. We also evaluated the impact of peripherally administered
acetate on motor activity in mice at similar low doses. In a sec-
ond group of experiments, because acetate accumulation after
repeated administration of ethanol seems to mediate tolerance
to LORR induced by ethanol (Kiselevski et al., 2003), we evalu-
ated the impact of chronic consumption of acetate across multiple
time periods on different behaviors modulated by an acute dose
of ethanol in mice. Thus, we evaluated the impact of chronic
exposure to acetate on ethanol-induced stimulation of locomo-
tion and on ethanol-induced LORR in mice. Moreover, although
acutely administered acetate has not shown to have an effect on
anxiety measures in mice (Escrig et al., 2007, 2012) and rats
(Correa et al., 2003), the anxiolytic actions of ethanol at low
doses are well known (Correa et al., 2008). Thus, in the present
study we also evaluated the impact of chronic administration of
acetate onmeasures of anxiolysis induced by a low dose of ethanol
in mice.
METHODS
SUBJECTS
Male Sprague-Dawley rats (Harlan Sprague-Dawley,
Indianapolis, IN), were housed in a colony maintained at
23◦C with lights on from 7:00 to 19:00 h. Animals weighed
between 350 and 430 g at the time of the experiment. These
animals had ad libitum access to food and water in their home
cages. Before the test day, rats were allowed 2 weeks to acclimate
to laboratory conditions, plus 1 week of being handled by the
experimenter for 5min each day. For the IP study, a total of 43
rats (n = 8–9 per group) were used and for the intraventricular
(ICV) study the number was 38 (n = 8–10 per group).
CD1 male mice (30–40 g) were purchased from Harlan-
Interfauna Iberica S.A. (Barcelona, Spain). Mice 6–7 weeks old
at the beginning of experiments were housed in groups of three
per cage, with standard laboratory rodent chow and tap water
available ad libitum. They were maintained in the colony at
22 ± 1◦C with lights on from 8:00 to 20:00 h. Mice were han-
dled and habituated to the test room for 1 week before tests
were conducted. For the acute acetate study, 42 mice were used
(n = 10–11 per group). For the chronic acetate studies, the loco-
motion experiment included 78 mice (n = 8–9 per group), the
anxiety experiment included a total of 63 mice (n = 10–11 per
group), and for the LORR experiments the total number was 218
(n = 14 per group).
All experimental procedures were approved by the
Institutional Animal Care and Use Committee, and complied
with the European Community Council directive (86/609/ECC)
for the use of laboratory animal subjects and with the “Guidelines
for the Care andUse of Mammals in Neuroscience and Behavioral
Research” (National Research Council, 2003).
DRUGS AND SELECTION OF DOSES
Anhydrous sodium acetate (hereafter referred to as acetate, Fisher
Scientific) was dissolved in physiological saline for the IP studies,
in artificial cerebrospinal fluid (aCSF) for the ICV studies, and in
tap water for the oral chronic studies. These vehicles serve as the
control solutions. For IP injections, acetate 10% w/v was used as
the stock solution from which the different doses were obtained.
ICV acetate doses of 0.7, 1.4, or 2.8μmoles (0.0, 42.03, 84.07, or
168.14μg), were administered in 1.0μl total volume. Chronically
administered acetate was prepared dissolving sodium acetate in
tap water. Concentration of the solutions were 500 or 1000mg/l.
After recording fluid intake and body weight per animal for 60
days, we calculated that the average dose of acetate consumed
for the group exposed to 500mg/l was 29.9 ± 5.3mg/kg and for
the 1000mg/l group was 67.6 ± 1.8mg/kg. Ethanol (96% v/v,
Panreac Quimica S. A.) was dissolved in physiological saline in a
20% v/v solution used as the stock solution fromwhich the differ-
ent doses were obtained. Hydrochloric acid (1N, PanreacQuimica
S. A.) was used to bring the sodium acetate solutions for the acute
studies to pH 7.4. Xylazine and Ketamine were purchased from
Phoenix Pharmaceutical, Inc. (St. Joseph, Mo).
The selection of doses and times was based on pilot stud-
ies and on previous studies from our laboratory (Arizzi et al.,
2003; Arizzi-LaFrance et al., 2006; Correa et al., 2003; Escrig et al.,
2012).
SURGICAL PROCEDURE AND ICV INJECTIONS
For the ICV study, rats were implanted with unilateral guide
cannulae (10.0mm length, 23 ga.). Rats were anesthetized with
a solution (1.0ml/kg, IP) that contained Ketamine (100mg/ml)
and Xylazine (20mg/ml). The stereotaxic coordinates for the can-
nulation into the lateral ventricle were as follows: AP −0.5mm
(from bregma), DL +1.3mm lateral (from midline), and DV
−3.0mm ventral (from the surface of the skull). The incisor bar
on the stereotax was set to 0.0mm above the interaural line. All
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animals were single housed following surgery, and were allowed
to recover for 7–10 days before behavioral testing. Stainless steel
stylets were kept in each guide cannulae to maintain its integrity.
ICV injections were made via 30 ga. stainless steel injection
cannulae extending 1.5mm below the guide cannulae. The injec-
tors were attached to 10.0μl Hamilton syringes by PE-10 tubing,
and were driven by a syringe pump (Harvard Apparatus) at a rate
of 0.5μl/min for a total volume of 1.0μl. Following the infu-
sion period the injectors were left in place for 1min to allow for
diffusion of the drug, after which the injectors were removed,
stylets were replaced, and animals were immediately placed into
the behavioral chambers for testing.
HISTOLOGY
For the ICV experiments, the placements of the injectors were
verified histologically. After the experiments were completed, all
animals were intracardially perfused with heparinized physiolog-
ical saline. Brains were stored refrigerated in 3.7% formaldehyde
solution for at least 5 days prior to slicing. Consecutive 50 micron
sections through the relevant brain areas were collected, mounted
on slides, and stainedwith cresyl violet solution to aid in detection
of the injector tracts. Coverslipped slides were viewed micro-
scopically to assess accuracy of implantation. Any animal with
improper placement, or significant damage around the injection
site, was not included in the statistical analyses of behavioral data.
A total of 5 animals were rejected due to bad placements.
APPARATUS AND BEHAVIORAL PROCEDURE IN RATS
Enclosed stabilimeter
Locomotor testing was performed in an automated activity cham-
ber (28 × 28 × 28 cm), which was inside a sound-proof shell. The
floor of the chamber consisted of two moveable wire mesh pan-
els (27 × 13 cm) mounted 6.0 cm above the chamber floor on
a center rod attached at either end to the sides of the cham-
ber; this allowed for slight vertical movement of the floor panels.
Movement of the panels was detected by microswitches mounted
outside the chamber at the ends of the panels. A depression
of a given quadrant (quadrant = 1/2 of each panel) would
close the circuit on the microswitch attached to the panel. Each
microswitch closure was counted as a single activity count, and
activity counts were recorded by a computer in 10min intervals.
Rats were habituated to the chamber and to injections prior to
the drug test. This was done to decrease activational effects due
to novelty on the test day. On the test day, animals were placed
into the activity chamber immediately after IP injections, and for
the ICV studies they were placed in the chambers after 1min to
allow for diffusion of the drug, as described above. Locomotion
was recorded in 10min periods. In the ICV studies, after drug
injections animals were anesthetized and perfused as described
above, and histological analyses of brain sections were performed.
APPARATUS AND BEHAVIORAL PROCEDURES IN MICE
Enclosed activity box
The enclosed locomotion chamber was made of polypropylene
and consisted of a square white box divided in two compartments
(25 cmW × 25 cmH × 22 cm L), covered with a translucent ceil-
ing. The behavioral test room was illuminated with a soft red
light, and external noise was attenuated. As in the stabilimeter,
this enclosed two-compartment box was used in order to mini-
mize anxiogenic stimulation of locomotion.Mice were habituated
to the chamber and to injections prior to the drug test. This was
done to decrease activational effects due to novelty on the test day.
Acetate IP was injected 10min before test started. Locomotion
was recorded for 10min. An activity count was registered by a
trained observer, unaware of the experimental condition, each
time the animal crossed from one quadrant to another with all
four legs.
Open Field (OF)
The OF arena consisted of a Plexiglass cylinder with translucent
walls (30 cm in diameter and 30 cm high) and an opaque floor
divided into four equal quadrants by two intersecting lines. Mice
were handled repeatedly and habituated to the test room before
the behavioral test, but were not pre-exposed to the OF. On the
test day, ethanol (1.0 or 2.0 g/kg) or saline were administered
acutely IP and animals were placed immediately in the OF and
locomotor observations started 10min later. The behavioral test
room was illuminated with a soft light, and external noise was
attenuated. An activity count was registered by a trained observer,
unaware of the experimental condition, each time the animal
crossed from one quadrant to another with all four legs.
Dark-light box
The apparatus consisted of a polypropylene chamber divided in
two compartments by a partition containing a small opening
(5 cm H × 5 cm W). The light compartment (25 cm W × 25 cm
H × 25 cm L) was open, painted in white, and illuminated, while
the dark compartment (25 cm W × 25 cm H × 18 cm L) was
painted in black and enclosed by a removable ceiling. This anxi-
ety paradigmmeasures the avoidance that rodents show to bright
open spaces. Several parameters were recorded during 5min test-
ing sessions. The dependent variables were: latency for the first
entry into the bright compartment from the dark one, latency to
go back to the dark compartment, total time spent in the bright
compartment, and total crosses between compartments. In the
acute study, acetate IP was injected 10min before the dark-light
box test.
LORR
Test of latency and duration of LORR were recorded consecu-
tively. Ethanol (4.0 or 4.5 g/kg) was injected IP, and immediately
mice were individually placed in a plexiglass cage. The latency
was defined as the time elapsed between ethanol injection and
LORR. Mice that did not lose righting reflex were not included
in the posterior measurements. After mice lost the righting reflex,
they were put on their back in a V-shape bed. The duration of
LORR was defined as the time elapsed from LORR to the time that
righting reflex was regained. Recovery was determined whenmice
could right themselves twice in 1min after being placed on their
backs. All the animals recovered the righting reflex. The behav-
ioral room was illuminated with a soft light and external noise
was attenuated.
These parameters were chosen based on previous studies
(Correa et al., 1999, 2001, 2003, 2008; Arizzi-LaFrance et al., 2006;
Chuck et al., 2006; Escrig et al., 2012).
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STATISTICAL ANALYSIS
All the experiments used a between-groups design, with each
animal only being tested once. Data were analyzed by simple
analysis of variance (ANOVA). If there was a significant over-
all drug effect, the LSD was used to make planned comparisons
between each dose and the respective vehicle control condition. A
computerized statistical program was used to analyze these data
(SPSS 10.0).
RESULTS
EXPERIMENT 1: EFFECT OF ACUTE CENTRAL OR PERIPHERAL
ADMINISTRATION OF ACETATE ON LOCOMOTOR ACTIVITY IN RATS
Figure 1A shows the effect of ICV acetate administration (0.0,
0.7, 1.4, or 2.8μmoles) on locomotor activity in the stabilime-
ter. Because the pattern of results was the same in the two
time periods registered and there was no interaction, separate
ANOVAs were performed for the two periods. The One-Way
ANOVA for the 0–10 period showed a statistically significant
overall treatment effect [F(3, 22) = 7.82, p < 0.01]. Planned com-
parisons showed all doses of acetate were significantly differ-
ent from vehicle (0.7 and 2.8μmoles p < 0.01, and 1.4μmoles
p < 0.05). The same pattern of results were found for the
ANOVA of the second period [F(3, 22) = 8.47, p < 0.01]. The
data for the effect of IP acetate administration (0, 12.5, 25,
50, or 100mg/kg) on locomotor activity in the stabilimeter
were analyzed in the same way (see Figure 1B). The One-
Way ANOVA for the first period of time showed a signifi-
cant effect of the peripheral dose of acetate [F(4, 36) = 4.90,
p < 0.01], and the planned comparisons showed that the three
highest doses were significantly different from vehicle (p <
0.01). The same results were shown for the second period of
time; 10–20min [F(4, 36) = 4.86, p < 0.01], and for the planned
comparisons.
EXPERIMENT 2: EFFECT OF ACUTE IP ADMINISTRATION OF ACETATE
ON LOCOMOTOR ACTIVITY IN MICE
The one-way factorial ANOVA for the effect of acetate treat-
ment (0, 50, 100, or 200mg/kg) did not show significant effects
on the number of crossings between the two compartments of
the enclosed box [F(3, 38) = 0.63, n.s.]. These data are shown in
Figure 2.
EXPERIMENT 3: EFFECT OF 15 DAYS OF ORAL CONSUMPTION OF
ACETATE ON ETHANOL-INDUCED LOCOMOTION IN MICE
A two-way factorial ANOVA (concentration of acetate × dose
of ethanol) showed no effect of the acetate concentration factor
FIGURE 2 | Effect of acetate administered acutely IP on locomotor
activity evaluated in mice in the enclosed activity box. Data are
expressed as mean + SEM counts in 10min.
FIGURE 1 | Effect of acetate administered acutely ICV (A) or IP (B)
on locomotor activity evaluated in rats in the enclosed
stabilimeter. Data are expressed as mean + SEM counts in 10min
periods. ∗∗p < 0.01, ∗p < 0.05 different from vehicle in the 0–10min
period. ##p < 0.01, #p < 0.05 different from vehicle in the 10–20min
period.
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[F(2, 69) = 1.42, n.s.], but a significant effect of the ethanol dose
factor [F(2, 69) = 9.50, p < 0.01], and a significant interaction
[F(4, 69) = 2.76, p < 0.05]. Planned comparison revealed that the
two doses of ethanol significantly induced locomotion (1.0 g/kg
p < 0.05 and 2.0 g/kg p < 0.01) compared to vehicle in the water-
consuming group. Moreover, these differences disappeared in the
acetate consuming groups. These results are depicted in Figure 3.
EXPERIMENT 4: EFFECT OF 15 DAYS OF ORAL CONSUMPTION OF
ACETATE ON ETHANOL-INDUCED ANXIOLYSIS IN MICE
The four dependent variables (see Table 1) were analyzed inde-
pendently. A two-way factorial ANOVA (concentration of acetate
× dose of ethanol) was performed in every case. The results
of the ANOVA for the dependent variable latency to enter the
bright compartment showed that there was a significant effect
of the ethanol dose [F(1, 57) = 4.72, p < 0.05], but no effect of
the acetate treatment [F(2, 57) = 0.36, n.s.], and no significant
interaction [F(2, 57) = 0.57, n.s.]. The same pattern of results for
the dependent variable latency to come back to the dark com-
partment was found: ethanol dose [F(1, 57) = 5.32, p < 0.05], the
concentration of acetate [F(2, 57) = 0.46, n.s.], and the interaction
FIGURE 3 | Effect of chronic acetate consumption during 15 days on
ethanol-induced locomotor activity in an open field in mice. Data are
expressed as mean ± SEM counts in 10min. ∗∗p < 0.01, ∗p < 0.05
different from vehicle in the same acetate group. ##p < 0.01 different from
the same dose of ethanol in the 0mg/l group.
[F(2, 57) = 0.78, n.s.]. These results demonstrate that ethanol had
an anxiolytic effect independently of the acetate treatment. The
results for the total time in the bright compartment showed no
significant effect: ethanol dose [F(1, 57) = 2.67, n.s.], acetate treat-
ment [F(2, 57) = 0.82, n.s.], and the interaction [F(2, 57) = 0.68,
n.s.]. The frequency of crossings between the bright and the
dark compartments showed a marginally non-significant effect
of the ethanol factor [F(1, 57) = 3.28, p = 0.07], a significant
effect of the acetate treatment [F(2, 57) = 3.53, p < 0.05], but no
significant interaction [F(2,57) = 0.52, n.s.].
EXPERIMENT 5: EFFECT OF ORAL CONSUMPTION OF ACETATE DURING
DIFFERENT PERIODS OF TIME ON ETHANOL-INDUCED LORR IN MICE
Animals received ethanol only once and different measures were
assessed. We observed that the lower dose of ethanol (4.0 g/kg)
did not produce LORR in some animals that were immedi-
ately excluded from the following measures in this experiment
(they are not included in the latency and duration analyses).
Grouping together the number of animals in the three treat-
ment groups (water, 500 and 1000mg/l) independently of how
many days they had consumed acetate (15, 30, or 60 days, there
were no animals in the 7 days groups), the χ2 test for indepen-
dence showed a significant effect of the acetate treatment (χ2 =
10.64, df = 2, p < 0.01). These data are depicted as percent-
age of animals not achieving LORR in every treatment group in
Figure 4.
Among the animals that did achieve LORR, a two-way facto-
rial ANOVA (concentration of acetate × time of consumption)
for the latency to reach LORR measure yielded no significant
effect of acetate concentration [F(2, 163) = 0.54, n.s.], no effect
of time of consumption [F(3, 163) = 1.48, n.s], and no interac-
tion [F(6, 163) = 0.79, n.s.]. The factorial ANOVA for duration
of LORR demonstrate no effect of the acetate concentration
[F(2, 163) = 0.07, n.s.], but a significant effect of the time of
consumption [F(3, 163) = 14.28, p < 0.01]. However, the inter-
action was not significant [F(6, 163) = 0.20, n.s.]. Thus, 4.0 g/kg
ethanol produced an increase in duration of LORR in older
animals independently of the acetate treatment. The data for
the higher dose of ethanol (4.5 g/kg) in animals consuming
acetate during 60 days were analyzed separately by means of a
One-Way ANOVA. The results show no effect of the concen-
tration on either the latency [F(2, 40) = 0.43, n.s.], or the dura-
tion of LORR [F(2, 40) = 0.62, n.s.]. These data are presented in
Figures 5A,B.
Table 1 | Effect of chronic acetate consumption during 15 days on vehicle or ethanol (1 g/kg, IP) treated mice in measures of anxiety in the
dark/light box.
Acetate (mg/l) Latency to lit compartment Latency to go back to Time in lit compartment Number of crossings into the
dark compartment lit compartment
Veh EtOH Veh EtOH Veh EtOH Veh EtOH
0 11.6± 1.8 9.4 ± 1.6 6.6 ± 1.9 14.6 ± 2.9 105.9 ± 10.9 122.8 ± 14.5 27.7 ± 3.1 30.8 ± 3.7
500 11.2± 1.9 6.6 ± 1.5 7.5 ± 1.8 9.6 ± 1.4 128.2 ± 10.6 129.3 ± 6.6 27.2 ± 3.3 37.4 ± 2.8
1000 15.3 ± 6.5 7.2 ± 1.3 8.7 ± 1.4 12.4 ± 3.2 110.0 ± 11.2 137.1 ± 11.6 37.2 ± 4.8 40.8 ± 4.1
Data are expressed as the mean ± SEM seconds or counts in 5min.
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EXPERIMENT 6: EFFECT OF ORAL CONSUMPTION OF ACETATE DURING
DIFFERENT PERIODS OF TIME ON VOLUME OF WATER CONSUMED
AND BODYWEIGHT GAIN
Results from the evolution of body weight and fluid intake in ani-
mals for experiment 5 are shown in Figures 6A,B. The Two-Way
ANOVA for the body weight was analyzed with a within factor for
duration of treatment and a between factor for concentration of
acetate. There was a significant effect of the duration [F(4, 960) =
437.5, p < 0.01], but no effect of concentration [F(2, 10) = 0.40,
FIGURE 4 | Percentage of mice exposed to different concentrations of
acetate that did not achieve LORR after receiving 4.0g/kg ethanol IP.
n.s.], and no significant interaction [F(8, 2) = 0.84, n.s.]. The
same pattern of results was shown for the fluid intake variable.
The Two-Way ANOVA showed a significant effect of the dura-
tion [F(4, 11) = 15.43, p < 0.01], but no effect of concentration
[F(2, 10) = 0.11, n.s.], and no significant interaction [F(8, 1) =
0.58, n.s.].
DISCUSSION
Studies of the behavioral effects of the ethanol metabolite
acetaldehyde have been increasing in number, especially dur-
ing the last decade; as a result, our knowledge of acetaldehyde’s
behavioral and neurochemical effects is quite comprehensive (for
a recent review see Correa et al., 2012). However, acetate has
remained mostly unknown, and only a handful of studies have
addressed its behavioral and neurochemical actions (Israel et al.,
1994; Correa et al., 2003; Kiselevski et al., 2003; Arizzi-LaFrance
et al., 2004; McLaughlin et al., 2008; Zimatkin et al., 2011; Escrig
et al., 2012). The present results demonstrate that acute low
doses of acetate administered peripherally or into the ventricles
reduce spontaneous locomotion in rats at least during 20min (see
Figures 1A,B). The present studies measured locomotion in small
and enclosed stabilimeter cages. Centrally administered acetate
(ICV) has also been shown to produce locomotor suppressant
effects in rats in an open field arena (Correa et al., 2003). In that
case acetate produced a monotonic decrease in activity (1.4 and
2.8μmoles) marked by significant decreases in locomotion as well
as rearing (Correa et al., 2003). The suppression is more effica-
cious when using the small stabilimeter cages (0.7μmoles also
suppressed locomotion), possibly because this device is less anx-
iogenic than the open field, and therefore induces a higher level
of locomotion.
FIGURE 5 | Effect of chronic acetate consumption during different periods of time on latency (A) and duration (B) to LORR induced by an acute
administration of ethanol (4.0 or 4.5g/kg, IP). Data are expressed as mean ± SEM of time in seconds.
Frontiers in Behavioral Neuroscience www.frontiersin.org July 2013 | Volume 7 | Article 81 | 6
Pardo et al. Acetate and suppression of locomotion
FIGURE 6 | Evolution of body weight (g) (A) and volume of fluid consumed (ml) (B) in animals exposed for 60 days to different concentrations of
acetate. Mean ± SEM of grams.
Rats seem to be more sensitive than mice to the suppressant
effects of peripherally administered ethanol and acetate. Thus,
in the present studies acetate doses between 25 and 100mg/kg
reduced locomotion in rats but not in mice; even the dose
of 2.0mg/kg did not suppress locomotion in mice under the
present conditions (enclosed activity box); this dose is much
lower than doses used in previous studies in mice (Israel et al.,
1994). In mice the minimal dose of acetate effective for sup-
pressing locomotion in an open field was 1.0 g/kg, while the
dose of ethanol was 3.0 g/kg (Israel et al., 1994). Thus, acetate
seems more potent than ethanol at suppressing locomotion.
This difference in drug potency has also been observed in
other studies in rats. When injected peripherally, acetate was
more potent than ethanol or acetaldehyde for suppressing food-
reinforced operant responding (Arizzi et al., 2003; McLaughlin
et al., 2008), reducing the number of fast responses and increas-
ing the number of pauses that the animals took during the
operant session at doses of 200–400mg/kg, IP (McLaughlin
et al., 2008). Injected into the ventricles, acetate suppressed
lever pressing (2.8 and 5.6μmoles), and also increased the
number of pauses at the highest concentration (5.6μmoles;
McLaughlin et al., 2008), while ethanol and acetaldehyde did
not. Moreover, acetate at the highest doses (5.6 and 8.8μmoles)
was also the most efficacious of the three substances at sup-
pressing lever pressing in an operant schedule of reinforce-
ment that generates very low rates of response, and thus is
very difficult to suppress [i.e., the differential-reinforcement-
of-low-rates-of-responding (DRL) 30 s schedule, Arizzi et al.,
2003].
While in the present experiments acute administration of
acetate was demonstrated to suppress locomotion, at least in
rats, chronic administration of acetate in the drinking water for
15 days did not change locomotion on its own. Nevertheless, it
did reduce ethanol-induced locomotion in the open field (see
Figure 3). Thus, chronic pre-exposure to a low dose of acetate
made animals more resistant to the stimulating effects of medium
doses of ethanol in mice. Acetate, however, does not seem to
mediate other ethanol well known effects, such as the anxiolytic
response which acetaldehyde has been demonstrated to regu-
late (Correa et al., 2003, 2008; Escrig et al., 2007, 2012). Acutely
administered acetate (50–200mg/kg, IP) did not alter the behav-
ior of mice in either the elevated plus maze or the dark and
light box (Escrig et al., 2007, 2012). The same pattern of effects
was observed in the interior part of an OF (Correa et al., 2003).
Acutely administered acetate ICV at doses similar to the present
ones (0.35–2.8μmoles) did not modify anxiety measures in the
open field in rats, although it reduced locomotion (Correa et al.,
2003). Moreover, in the present results, mice exposed to acetate
for 15 days did not show changes in the anxiolytic response in the
dark/light box after ethanol administration. The dose of ethanol
used (1.0 g/kg) has previously been demonstrated to have a potent
anxiolytic effect under the present conditions (Correa et al., 2008;
Escrig et al., 2012). Unfortunately, that anxiolytic effect was very
mild in the present results, thus we cannot rule out this fact as
the lack of interaction. In summary, although acetate has been
shown to be involved in the locomotor suppressing effects of
ethanol in mice (Israel et al., 1994) and rats (Correa et al., 2003;
Arizzi-LaFrance et al., 2004; present results), it does not seem to
mediate ethanol’s anxiolytic actions (Correa et al., 2003), nor does
it seem to be involved in the anxiogenic response produced by
a bolus injection of acetaldehyde in the periphery (Escrig et al.,
2012).
The higher levels of acetate that accumulate in the brain after
repeated administration of ethanol (3.5 g/kg, IP, during 7 days)
seem to mediate tolerance to LORR induced by an acute dose
of ethanol (3.5 g/kg) in outbred rats (Kiselevski et al., 2003).
Moreover, there is evidence that higher amounts of acetate are
formed in SS rats that have an inborn tolerance to hypnotic
doses of ethanol compared to the LS substrain (Zimatkin et al.,
2011). In the present studies with mice, the doses achieved
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FIGURE 7 | Schematic drawing showing ethanol regulation of
adenosine production, release, and uptake in striatum. Abbreviations:
A1R and A2AR, adenosine receptors; ACh, acetylcholine; ADH, alcohol
dehydrogenase; ALDH, aldehyde dehydrogenase; ATP, adenosine
triphosphate; AMP, adenosine monophosphate; CAT-H2O2, catalase;
CYP-2E1, cytochrome P4502E1; D1R and D2R, dopamine receptors; ENT,
equilibrative nucleoside transporters; M1R and M4R, muscarinic receptors;
MSN, medium spiny neuron.
after consuming water with acetate concentrations of 500 and
1000mg/l are significantly lower (around 30 and 65mg/kg per
day, respectively). Thus, the lack of effects in latency and dura-
tion of LORR after acute administration of the high doses of
ethanol (4.0 and 4.5 g/kg) could be due to the fact that the doses
achieved after consuming these concentrations of acetate are sig-
nificantly lower than the ones used in other studies. Also, these
discrepancies in results could be due to species differences; mice
been shown to be more resistant than rats to the suppressive
effects of ethanol and acetate. However, our results on number of
animals achieving LORR (Figure 4) indicate that chronic acetate
provides some sort of resistance in mice to the hypnotic effects of
ethanol.
The precise brain areas and neural mechanisms through which
acetate produces its potent suppression of motor activity are not
known. A potential neuroanatomical locus for the locomotor
actions of acetate, ethanol and acetaldehyde was previously found
(Arizzi-LaFrance et al., 2004, 2006). Acetate injected into the sub-
stantia nigra pars reticulata of the mesencephalon produced a
slight locomotor suppression (Arizzi-LaFrance et al., 2004) in
contrast to the clear stimulation demonstrated for ethanol and
acetaldehyde (Arizzi-LaFrance et al., 2006). Concentrations of
several neurotransmitters such as acetylcholine (ACh) and adeno-
sine seem to be modulated by the production of acetate. These
hypothetical mechanisms are summarized in Figure 7. Acetate
has demonstrated to increase the formation of adenosine (Dar
et al., 1983; Phillis et al., 1992; Carmichael et al., 1993; Israel
et al., 1994; Kiselevski et al., 2003). Ethanol increases adenosine
levels by acting as a precursor through the production of acetate
(Orrego et al., 1988; Carmichael et al., 1991). High doses of
sub-chronically administered ethanol have been demonstrated to
increase acetate, adenosine, and ACh, as well as several other bio-
chemical factors responsible of acetate, in several areas of the
brain (Kiselevski et al., 2003). It has also been suggested that
ethanol as well as acetate can block adenosine uptake into the neu-
ron (Fredholm and Wallman-Johansson, 1996; Kiselevski et al.,
2003; Correa and Font, 2008), thus increasing extra-synaptic
adenosine levels. Adenosine has been implicated in multiple
behaviors including sleep, arousal, and motor activity (Huston
et al., 1996; Iversen et al., 2009). There is evidence that adeno-
sine may contribute to some behavioral effects of ethanol such
as sedation, and motor suppression or incoordination (Proctor
et al., 1985; Clark and Dar, 1988, 1989; Dar, 1990, 1993, 2000;
Carmichael et al., 1991; Meng and Dar, 1995; Campisi et al.,
1997; Barwick and Dar, 1998). Motor incoordination induced by
ethanol is controlled by adenosine in the striatum and cerebel-
lum (Dar, 1993; Meng and Dar, 1995). Studies also indicate that
adenosine receptor activation provides a major contribution to
motor suppressant effects of low concentrations of ethanol when
the production of acetate is near maximal (Carmichael et al.,
1993; Israel et al., 1994). At higher doses of ethanol, such as the
ones used in LORR studies, the role of the acetate–adenosine
system is proportionately reduced (Israel et al., 1994). As the
acetate level increases after high doses of ethanol, the activation
of acetyl–CoA synthetase would be expected and the formation of
ACh is then potentiated (Kiselevski et al., 2003). Acetate induced
increases in ACh in cerebral cortex have been associated to tol-
erance to ethanol-induced LORR (Zimatkin et al., 2011). Thus,
the present results suggest that an increase in ACh/adenosine
content may be responsible for the effects of acetate on locomo-
tor suppression, and for blocking the stimulation of locomotion
induced by ethanol and increasing resistance to achieve LORR.
Further studies about the involvement of ACh, adenosine, and
their subtype-receptors in these actions of acetate are warranted.
The relevance of the present acetate results (i.e., suppression
of locomotion, blockade of ethanol stimulation) is related to the
suggestion that two pharmacological effects that may be particu-
larly relevant for alcohol consumption are behavioral stimulation
and sedation (King et al., 2002, 2011). In general, doses of ethanol
that produce more stimulation are more likely to be consumed.
Subjects report that their typical drinking bout is in the dose
range that was considered as having activating or disinhibiting
effects (King et al., 2002, 2011). Sedative or suppressing effects on
activationmay also influence drinking behavior; anticipated seda-
tive effects vary inversely with alcohol consumption (Earleywine
and Martin, 1993) and heavier drinkers anticipate fewer seda-
tive effects of alcohol than lighter drinkers (O’Malley and Maisto,
1984). Thus, sedative effects seem to prevent self-administration
of ethanol, and stimulant effects can foster consumption of this
drug. In agreement with these hypotheses, rats do not self-
administer acetate ICV under the same conditions that lead
to ethanol or acetaldehyde self-administration (Rodd-Henricks
et al., 2002), and acetate does not stimulate locomotion under the
same conditions that ethanol and acetaldehyde do (Correa et al.,
2003).
Frontiers in Behavioral Neuroscience www.frontiersin.org July 2013 | Volume 7 | Article 81 | 8
Pardo et al. Acetate and suppression of locomotion
ACKNOWLEDGMENTS
This research was supported by a grant to Mercè
Correa from Plan Nacional de Drogas (2010I024), Spain,
and a grant to John D. Salamone from NIH/NIMH
(MH078023-01A1), USA. Marta Pardo was funded by a
fellowship from Fundació Bancaixa-UJI (PREDOC2007-
43), Laura López-Cruz was funded by a fellowship from
Ministerio de Educación FPU (AP2010-3793), and Noemí
San Miguel was supported by Plan Nacional de Drogas
(2010I024).
REFERENCES
Arizzi-LaFrance, M. N., Correa, M.,
Aragon, C. M., and Salamone,
J. D. (2006). Motor stimulant
effects of ethanol objected into the
substantia nigra pars reticulata:
importance of catalase-mediated
metabolism and the role of acetalde-
hyde. Neuropsychpharmacology 31,
997–1008. doi: 10.1038/sj.npp.
1300849
Arizzi-LaFrance, M. N., Correa,
M., and Salamone, J. D. (2004).
Locomotor activating effects of
ethanol and ethanol metabolites
after injection into the substantia
nigra pars reticulata: effects of
catalase blockade. Alcohol. Clin.
Exp. Res. 28, 61A.
Arizzi, M. N., Correa, M., Betz, A.
J., Wisniecki, A., and Salamone,
J. D. (2003). Behavioral effects of
intraventricular injections of low
doses of ethanol, acetaldehyde, and
acetate in rats: studies with low
and high rate operant schedules.
Behav. Brain Res. 147, 203–210. doi:
10.1016/S0166-4328(03)00158-X
Barwick, V. S., and Dar, M. S. (1998).
Adenosinergic modulation of
ethanol-induced motor incoor-
dination in the rat motor cortex.
Prog. Neuropsychopharmacol. Biol.
Psychiatry 22, 587–607. doi:
10.1016/S0278-5846(98)00025-6
Busch, H. (1953). Studies on the
metabolism of acetate-1-C in tissues
of tumor-bearing rats. Cancer. Res.
13, 789–794.
Campisi, P., Carmichael, F. J.,
Crawford, M., Orrego, H., and
Khanna, J. M. (1997). Role of
adenosine in the ethanol-induced
potentiation of the effects of
general anesthetics in rats. Eur.
J. Pharmacol. 325, 165–172. doi:
10.1016/S0014-2999(97)00124-6
Carmichael, F. J., Israel, Y., Crawford,
M., Minhas, K., Saldivia, V.,
Sandrin, S., et al. (1991). Central
nervous system effects of acetate:
contribution to the central effects
of ethanol. J. Pharmacol. Exp. Ther.
259, 403–408.
Carmichael, F. J., Orrego, H., and Israel,
Y. (1993). Acetate-induced adeno-
sine mediated effects of ethanol.
Alcohol Alcohol. 2, 411–418.
Chuck, T. L., McLaughlin, P. J., Arizzi-
LaFrance, M. N., Salamone, J. D.,
and Correa, M. (2006). Comparison
between multiple behavioral effects
of peripheral ethanol administra-
tion in rats: sedation, ataxia, and
bradykinesia. Life Sci. 79, 154–161.
doi: 10.1016/j.lfs.2005.12.045
Clark, M., and Dar, M. S. (1988).
Mediation of acute ethanol-induced
motor disturbances by cerebellar
adenosine in rats. Pharmacol.
Biochem. Behav. 30, 155–161. doi:
10.1016/0091-3057(88)90439-X
Clark, M., and Dar, M. S. (1989).
Effect of acute ethanol on
release of endogenous adenosine
from rat cerebellar synap-
tosomes. J. Neurochem. 52,
1859–1865. doi: 10.1111/j.1471-
4159.1989.tb07268.x
Correa, M., Chuck, T., Arizzi, M. N.,
Betz, A., McLaughlin, P. J., and
Salamone, J. D. (2003). Motor
effects of ethanol and ethanol
metabolites after intracranial or
peripheral injections in rats. Behav.
Pharmacol. 14, 76–77.
Correa, M., and Font, L. (2008). Is
there a major role of A2A adeno-
sine receptor in anxiety? Front.
Biosci. 1, 4058–4070. doi: 10.2741/
2994
Correa, M., Manrique, H. M., Font,
L., Escrig, M. A., and Aragon, C.
M. G. (2008). Reduction in the
anxiolytic effects of ethanol by
centrally formed acetaldehyde:
the role of catalase inhibitors
and acetaldehyde-sequestering
agents. Psychopharmacol. 200,
455–464. doi: 10.1007/s00213-008-
1219-3.
Correa, M., Miquel, M., Sanchis-
Segura, C., and Aragon, C. M.
(1999). Acute lead acetate adminis-
tration potentiates ethanol-induced
locomotor activity in mice: the role
of brain catalase. Alcohol. Clin. Exp.
Res. 23, 799–805.
Correa, M., Salamone, J. D., Segovia,
K. N., Pardo, M., Longoni, R.,
Spina, L., et al. (2012). Piecing
together the puzzle of acetaldehyde
as a neuroactive agent. Neurosci.
Biobehav. Rev. 36, 404–430. doi:
10.1016/j.neubiorev.2011.07.009
Correa, M., Sanchis-Segura, C., and
Aragon, C. M. (2001). Influence of
brain catalase on ethanol-induced
loss of righting reflex in mice.
Drug. Alcohol. Depend. 65, 9–15.
doi: 10.1016/S0376-8716(01)
00142-9
Cullen, N., and Carlen, P. L. (1992).
Electrophysiological actions of
acetate, a metabolite of ethanol,
on hippocampal dentate gran-
ule neurons: interactions with
adenosine. Brain Res. 588, 49–57.
doi: 10.1016/0006-8993(92)
91343-D
Dar, M. S. (1990). Central adenosiner-
gic system involvement in ethanol-
induced motor incoordination in
mice. J. Pharmacol. Exp. Ther. 255,
1202–1209.
Dar, M. S. (1993). Brain adenosiner-
gic modulation of acute ethanol-
induced motor impairment. Alcohol
Alcohol. Suppl. 2, 425–429.
Dar, M. S. (2000). Cerebellar
CB(1) receptor mediation of
Delta(9)-THC-induced motor
incoordination and its potentia-
tion by ethanol and modulation
by the cerebellar adenosin-
ergic A(1) receptor in the
mouse. Brain Res. 864, 186–194.
doi: 10.1016/S0006-8993(00)
02103-X
Dar, M. S., Mustafa, S. J., and Wooles,
W. R. (1983). Possible role of
adenosine in the CNS effects of
ethanol. Life. Sci. 33, 1363–1374.
doi: 10.1016/0024-3205(83)
90819-6
Earleywine, M., and Martin, C. S.
(1993). Anticipated stimulant and
sedative effects of alcohol vary with
dosage and limb of the blood alco-
hol curve. Alcohol. Clin. Exp Res.
17, 135–139. doi: 10.1111/j.1530-
0277.1993.tb00738.x
Escrig,M. A., Pardo, M., Aragon, C.M.,
and Correa, M. (2007). Anxiogenic
effects in mice of peripheral
acetaldehyde accumulation. Behav.
Pharmacol. 18, 77.
Escrig, M. A., Pardo, M., Aragon,
C. M., and Correa, M. (2012)
Anxiogenic and stress-inducing
effects of peripherally admin-
istered acetaldehyde in mice:
similarities with the disulfiram-
ethanol reaction. Pharmacol.
Biochem. Behav. 100, 404–412. doi:
10.1016/j.pbb.2011.10.002
Fredholm, B. B., and Wallman-
Johansson, A. (1996). Effects of
ethanol and acetate on adenosine
production in rat hippocampal
slices. Pharmacol. Toxicol. 79,
120–123. doi: 10.1111/j.1600-
0773.1996.tb00254.x
Huston, J. P., Haas, H. L., Boix, F.,
Pfister, M., Decking, U., Schrader,
J., et al. (1996). Extracellular
adenosine levels in neostria-
tum and hippocampus during
rest and activity periods of
rats. Neuroscience 73, 99–107.
doi: 10.1016/0306-4522(96)
00021-8
Israel, Y., Orrego, H., and Carmichael,
F. J. (1994). Acetate-mediated effects
of ethanol. Alcohol. Clin. Exp. Res.
18, 144–148. doi: 10.1111/j.1530-
0277.1994.tb00894.x
Iversen, L. L., Iversen, S. D.,
Bloom, F. E., and Roth, R.
H. (2009). Introduction to
Neuropsychopharmacology. New
York, NY: Oxford University Press.
King, A. C., de Wit, H., McNamara, P.
J., and Cao, D. (2011). Rewarding,
stimulant, and sedative alco-
hol responses and relationship
to future binge drinking. Arch.
Gen. Psychiatry 68, 389–399.
doi: 10.1001/archgenpsychiatry.
2011.26
King, A. C., Houle, T., de Wit, H.,
Holdstock., L., and Schuster, A.
(2002). Biphasic alcohol response
differs in heavy versus light
drinkers. Alcohol. Clin. Exp. Res.
26, 827–835. doi: 10.1111/j.1530-
0277.2002.tb02611.x
Kiselevski, Y., Oganesian, N., Zimatkin,
S., Szutowicz, A., Angielski, S.,
Niezabitowski, P., et al. (2003).
Acetate metabolism in brain
mechanisms of adaptation to
ethanol. Med. Sci. Monit. 9,
178–182.
Lundquist, F., Tygstrup, N., Winkler,
K., Mellemgaard, K., and Munck-
Petersen, S. (1962). Ethanol
metabolism and production of
free acetate in the human liver.
J. Clin. Invest. 41, 955–961. doi:
10.1172/JCI104574
McLaughlin, P. J., Chuck, T. L.,
Arizzi-LaFrance, M. N., Salamone,
J. D., and Correa, M. (2008).
Central vs. peripheral adminis-
tration of ethanol, acetaldehyde
and acetate in rats: effects on lever
pressing and response initiation.
Pharmacol. Biochem. Behav. 89,
304–313. doi: 10.1016/j.pbb.2008.
01.002
Meng, Z. H., and Dar, M. S. (1995).
Possible role of striatal adeno-
sine in the modulation of acute
Frontiers in Behavioral Neuroscience www.frontiersin.org July 2013 | Volume 7 | Article 81 | 9
Pardo et al. Acetate and suppression of locomotion
ethanol-induced motor incoordina-
tion in rats. Alcohol. Clin. Exp. Res.
19, 892–901. doi: 10.1111/j.1530-
0277.1995.tb00964.x
O’Malley, S. S., and Maisto, S. A. (1984)
Factors affecting the perception of
intoxication: dose, tolerance, and
setting. Addict. Behav. 9, 111–120.
doi: 10.1016/0306-4603(84)
90049-2
Oldendorf, W. H. (1973). Carrier-
mediated blood-brain barrier trans-
port of short-chain monocarboxylic
organic acids. Am J. Physiol. 224,
1450–1453.
Orrego, H., Carmichael, F. J., and Israel,
Y. (1988). New insights on the
mechanism of the alcohol-induced
increase in portal blood flow. Can.
J. Physiol. Pharmacol. 66, 1–9. doi:
10.1139/y88-001
Phillis, J. W., O’Regan, M. H., and
Perkins, L. M. (1992). Actions of
ethanol and acetate on rat cortical
neurons: ethanol/adenosine inter-
actions. Alcohol 9, 541–546. doi:
10.1016/0741-8329(92)90094-Q
Proctor, W. R., Baker, R. C.,
and Dunwiddie, T. V. (1985).
Differential CNS sensitivity
to PIA and theophylline in
long-sleep and short-sleep
mice. Alcohol 2, 387–391. doi:
10.1016/0741-8329(85)90061-8
Rodd-Henricks, Z. A., Bell, R. L., Kuc,
K. A., Murphy, J. M., McBride,
W. J., Lumeng, L., et al. (2002).
Effects of ethanol exposure on
subsequent acquisition and extinc-
tion of ethanol self-administration
and expression of alcohol-seeking
behavior in adult alcohol-preferring
(P) rats: II. Adult exposure. Alcohol.
Clin. Exp. Res. 26, 1642–1652.
doi: 10.1111/j.1530-0277.2002.
tb02466.x
Van den Berg, C. J., Mela, P., and
Waelsch, H. (1966). On the
contribution of the tricarboxylic
acid cycle to the synthesis of
glutamate, glutamine and aspar-
tate in brain. Biochem. Biophys.
Res. Commun. 23, 479–484.
doi: 10.1016/0006-291X(66)
90753-4
Zimatkin, S. M., Oganesian, N. A.,
Kiselevski, Y. V., and Deitrich,
R. A. (2011). Acetate-dependent
mechanisms of inborn tolerance
to ethanol. Alcohol Alcohol. 46,
233–238. doi: 10.1093/alcalc/agr014
Zimatkin, S. M., Pronko, S. P., Vasiliou,
V., Gonzalez, F. J., and Deitrich,
R. A. (2006). Enzymatic mecha-
nisms of ethanol oxidation in the
brain. Alcohol. Clin. Exp. Res. 30,
1500–1505. doi: 10.1111/j.1530-
0277.2006.00181.x
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 10 April 2013; accepted: 18
June 2013; published online: 10 July
2013.
Citation: Pardo M, Betz AJ, San Miguel
N, López-Cruz L, Salamone JD and
Correa M (2013) Acetate as an active
metabolite of ethanol: studies of locomo-
tion, loss of righting reflex, and anxiety
in rodents. Front. Behav. Neurosci. 7:81.
doi: 10.3389/fnbeh.2013.00081
Copyright © 2013 Pardo, Betz, San
Miguel, López-Cruz, Salamone and
Correa. This is an open-access article
distributed under the terms of the
Creative Commons Attribution License,
which permits use, distribution and
reproduction in other forums, provided
the original authors and source are cred-
ited and subject to any copyright notices
concerning any third-party graphics etc.
Frontiers in Behavioral Neuroscience www.frontiersin.org July 2013 | Volume 7 | Article 81 | 10
